Delta opioid receptor agonist reduces anxiety-like behavior in mice

Anxiety-related disorders can have a profound impact on the mental health and quality of life of affected individuals.

Intellia propels into 2024 with CRISPR pipeline updates – Pharmaceutical Technology

Share this article Intellia Therapeutics declared clinical updates for its CRISPR therapeutics portfolio. Credit: rafapress via Shutterstock Intellia Therapeutics teased its upcoming goals for several

January 5, 2024

Filling 12-month prescriptions is one practical way to help the pharmacist crisis

Pharmacies could be called the most “rock solid” entity in our health care system. Even before Covid, pharmacies were held in high esteem; during the

November 21, 2023

Cytovale Secures $100M to Expand Commercialization of FDA-Cleared Sepsis Test

What You Should Know: – Cytovale, a medical diagnostics company revolutionizing early disease detection secures $100M in Series D funding round led by Sands Capital

October 11, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.